BNO 5.26% 20.0¢ bionomics limited

Potential Target

  1. 593 Posts.
    lightbulb Created with Sketch. 24
    This extract (below) from * about a week ago (sorry for the late pick up) - Whilst it is * that wrote this (there is usually a bit of "inflammation" in the stories there), I think they have picked some of the more realistic acquisition targets including BNO. GLTA

    "Potential takeovers could include medical devices companies Impedimed (ASX:IPD), AirXpanders (ASX:AXP), Osprey (ASX:OSP) and Visioneering (ASX:VTI), and biotechs Paradigm Biopharma (ASX:BIO) and perhaps Bionomics (ASX:BNO)."
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.